Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2000
10/11/2000EP1042493A1 Equine infectious anaemia virus (eiav) based retroviral vectors
10/11/2000EP1042358A1 Free solution ligand interaction molecular separation method
10/11/2000EP1042000A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors
10/11/2000CN1269245A Static hydraulic process to prepare influenza virus vaccine
10/10/2000US6130074 Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
10/10/2000US6129922 Methods for adjuvant free hepatitis A virus vaccination
10/10/2000US6129920 Inactivated infectious bursal disease vaccine
10/10/2000CA2104396C Viral particles having altered host range
10/10/2000CA2002839C Parvovirus capsids
10/05/2000WO2000058487A2 Insect viral vectors and uses thereof
10/05/2000WO2000058485A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
10/05/2000WO2000058482A2 Transducing phages
10/05/2000WO2000058444A2 Adaptation of virus to vertebrate cells
10/05/2000WO2000058349A1 Peptide vaccine for canine allergy
10/05/2000WO2000057910A1 Attenuated dengue-4 virus vaccine
10/05/2000WO2000057909A2 Attenuated dengue-2 virus vaccine
10/05/2000WO2000057908A2 Attenuated dengue-1 virus vaccine
10/05/2000WO2000057907A2 Multivalent dengue virus vaccine
10/05/2000WO2000057904A2 Attenuated dengue-3 virus vaccine
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000026246A3 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
10/05/2000DE19915178A1 Hepatitis C Virus Zellkultursystem Hepatitis C virus cell culture system
10/05/2000CA2368835A1 Insect viral vectors and uses thereof
10/05/2000CA2368790A1 Attenuated dengue-3 virus vaccine
10/05/2000CA2368674A1 Multivalent dengue virus vaccine
10/05/2000CA2368673A1 Attenuated dengue-4 virus vaccine
10/05/2000CA2368119A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
10/05/2000CA2365728A1 Attenuated dengue-1 virus vaccine
10/05/2000CA2365635A1 Transducing phages
10/05/2000CA2365415A1 Adaptation of virus to vertebrate cells
10/05/2000CA2365411A1 Attenuated dengue-2 virus vaccine
10/05/2000CA2329152A1 Peptide vaccine for canine allergy
10/04/2000EP1041152A1 Retroviral vectors
10/04/2000EP1041141A1 A novel bacteriophage, a process for the isolation thereof and a universal growth medium useful in the process thereof
10/04/2000EP1040198A1 Recombinant rhabdovirus containing a heterologous fusion protein
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/03/2000US6127525 Coat protein having non-native, non-hexon amino acid sequence; allows decreased ability or inability to be recognized by neutralizing antibodies against wild-type protein; for gene therapy
10/03/2000US6127175 Cells for the production of recombinant adenoviruses
10/03/2000US6127172 Transforming cells by introducing into in vitro cell an amount of recombinant entomopox virus vector which includes polynucleotide which encodes desired protein linked to an early promoter sequence; gene therapy using large inserts
10/03/2000US6127164 Diagnosis using dna which specifically hybridizes under high stringency conditions to genomic dna of type 57
10/03/2000US6127163 Viral vector which codes exogenous proteins; for use as therapeutic tools in drug delivery
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6127113 Testing mammals for microorganismal induced dietetics; obtaining sample, testing for the presence of nucleotide sequences, screening for presence microorganismal nucleotide sequences
09/2000
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056909A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2366552A1 Method for detecting superantigen activity in a biological sample
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2361055A1 Viral agents
09/27/2000EP1038967A2 Virus with modified binding moiety specific for the target cells
09/27/2000EP1038952A2 Processes for preparation of Marek's Disease Virus using continuous avian cell lines
09/27/2000EP1038001A2 Constitutive expression of non-infectious hiv-like particles
09/27/2000EP1037917A1 Recombinant nodavirus compositions and methods
09/27/2000EP1037603A1 Membrane virus host range mutations and their uses as vaccine substrates
09/27/2000CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus
09/27/2000CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
09/26/2000US6123949 A vaccine which comprises an effective immunizing amount of the genetically engineered fowlpox virus designated s-fpv-043, useful for immunizing the animal against disease caused by fowlpox virus and newcastle disease virus
09/26/2000CA2103460C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
09/21/2000WO2000055378A1 Lentiviral vector system for high quantity screening
09/21/2000WO2000055342A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
09/21/2000WO2000055341A1 Anti-viral vectors
09/21/2000WO2000055335A1 Pseudotyped lentiviral vectors and uses thereof
09/21/2000WO2000054813A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000WO2000054730A2 Compositions preparations and uses of human papillomavirus l1 protein
09/21/2000WO2000039303A3 Modified hiv env polypeptides
09/21/2000WO2000020574A3 Fusions of scaffold proteins with random peptide libraries
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000DE19918023A1 Preparation of a liver cell-derived packaging cell line comprises stabile transfection of adenoviral E1 sequences of human hepatoma cells
09/21/2000DE19910650A1 Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren Based on HERV LTR sequences retroviral expression vectors
09/21/2000DE10013017A1 Verfahren zum Läutern eines viralen Antigens und zum Erzeugen eines Impfstoffes A method for refining a viral antigen and for producing a vaccine
09/21/2000CA2367375A1 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000CA2366054A1 Lentiviral vector system for high quantity screening
09/20/2000EP1036182A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
09/20/2000EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
09/20/2000CN1267330A Method for inactivating virus
09/19/2000US6121036 Purified, host-specific, nontoxic, wide host range, virulent preparation against staphylococcus, helicobacter, mycobacterium, streptococcus, klebsiella, enterobacter, proteus, bacteriodes, pseudomonas, escherichia and others
09/19/2000US6121021 Modified human immunodeficiency virus genome devoid of long terminal repeats, with vpr and tat sequences disabled, and linked to constitutive promoter; for stable, long-term production of nonreplicating immunogens for vaccines
09/19/2000US6121007 Reaction-based selection for expression of and concentration of catalytic moieties
09/19/2000US6120773 Recombinant herpes simplex viruses vaccines and methods
09/19/2000US6120764 Genetic engineering
09/14/2000WO2000053789A2 Retroviral expression vectors on the basis of herv- long terminal repeat sequences
09/14/2000WO2000053788A2 Compositions and methods for recombinant adeno-associated virus production
09/14/2000WO2000053787A1 Prrsv vaccines
09/14/2000WO2000053786A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000WO2000053766A1 Non-spreading pestivirus
09/14/2000WO2000053729A2 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
09/14/2000WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
09/14/2000WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
09/14/2000DE19910044A1 Virale Partikel, die nach Infektion durch humanes Cytomegalovirus freigesetzt werden und ihre Verwendung als Impfstoff Viral particles released after infection by human cytomegalovirus and their use as a vaccine
09/14/2000CA2365903A1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
09/14/2000CA2365813A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000CA2365293A1 Compositions and methods for recombinant adeno-associated virus production
09/14/2000CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization
09/13/2000EP1035210A2 SIVagm-derived lentiviral vectors, processes for their preparation and their application in the gene transfer in mammalian cells
09/13/2000EP1035209A1 Stable recombinant influenza viruses free of helper viruses
09/13/2000EP1035208A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 267